3d bioprinting market
3D Bioprinting Market, By Technology (Syringe/extrusion Bioprinting, Inkjet Bioprinting, Magnetic Levitation Bioprinting, Laser-assisted Bioprinting, and Others), By Component (3D Bioprinters, Biomaterials, and Scaffolds), By Application (Drug Testing and Development, Regenerative Medicine, Food Testing, Research, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
- Mar 2024
- CMI5166
- 168 Pages
- Excel & Pdf
- Smart Technologies
Summary
N/A
Table of Content
Table of Contents:
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Component
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Market Dynamics
- Global 3D Bioprinting Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- Global 3D Bioprinting Market, By Technology, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020-2031
- Segment Trends
- Syringe/ extrusion bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Inkjet Bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Magnetic Levitation Bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Laser Assisted Bioprintings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Other Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Introduction
- Global 3D Bioprinting Market, By Component, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020-2031
- Segment Trends
- 3D Bioprinters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Biomaterials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Scaffolds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Introduction
- Global 3D Bioprinting Market, By Application, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020-2031
- Segment Trends
- Drug Testing and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Food Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Introduction
- Global 3D Bioprinting Market, By Region, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020-2031
- Country Trends
- North America
- Regional Trends
- Market Size and Forecast, By Technology, 2019–2031 (USD Billion)
- Market Size and Forecast, By Components, 2019–2031 (USD Billion)
- Market Size and Forecast, By Application, 2019–2031 (USD Billion)
- Market Share Analysis, By Country, 2024 and 2031 (%)
- U.S.
- Canada
- Europe
- Regional Trends
- Market Size and Forecast, By Technology, 2019–2031 (USD Billion)
- Market Size and Forecast, By Components, 2019–2031 (USD Billion)
- Market Size and Forecast, By Application, 2019–2031 (USD Billion)
- Market Share Analysis, By Country, 2024 and 2031 (%)
- U.K.
- Germany
- France
- Russia
- Rest of Europe
- Asia Pacific
- Regional Trends
- Market Size and Forecast, By Technology, 2019–2031 (USD Billion)
- Market Size and Forecast, By Components, 2019–2031 (USD Billion)
- Market Size and Forecast, By Application, 2019–2031 (USD Billion)
- Market Share Analysis, By Country, 2024 and 2031 (%)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Regional Trends
- Market Size and Forecast, By Technology, 2019–2031 (USD Billion)
- Market Size and Forecast, By Components, 2019–2031 (USD Billion)
- Market Size and Forecast, By Application, 2019–2031 (USD Billion)
- Market Share Analysis, By Country, 2024 and 2031 (%)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast, By Technology, 2019–2031 (USD Billion)
- Market Size and Forecast, By Components, 2019–2031 (USD Billion)
- Market Size and Forecast, By Application, 2019–2031 (USD Billion)
- Market Share Analysis, By Country/region, 2024 and 2031 (%)
- South Africa
- GCC Countries
- Rest of the Middle East & Africa
- Introduction
- Competitive Landscape
- Company Profiles
- 3D Bioprinting Solutions*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Advanced Solutions Life Sciences, LLC
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Allevi Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Aspect Biosystems Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Bico group ab
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Bio3D Technologies Pte. Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Cellink Global
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Collplant Biotechnologies Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Cyfuse Biomedical K.K.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Electro Optical Systems
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Envisiontec GmbH
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Foldink Life Science Technologies
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Formlabs, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- GE Healthcare
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Inventia Life Science PTY LTD
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Nano 3D Biosciences, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Optomec Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Organovo Holdings, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Pandorum Technologies pvt. ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Precise Bio
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Regemat 3D S.L.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Regenovo Biotechnology Co. Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Renishaw PLC.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Revotek Co., Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Rokit Healthcare, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Stratasys Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- Vivax Bio, LLC
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments/Updates
- 3D Bioprinting Solutions*
- Company Profiles
- Wheel of Fortune
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- Section:
- Research Methodology
- About Us
*Browse 24 market data tables and 28 figures on "Global 3D Bioprinting Market” - Global forecast to 2031
Segmentation
Market Segmentation
- By Technology
- Syringe/extrusion Bioprinting
- Inkjet Bioprinting
- Magnetic Levitation Bioprinting
- Laser-assisted Bioprinting
- Others
- By Component
- 3D Bioprinters
- Biomaterials
- Scaffolds
- By Application
- Drug Testing and Development
- Regenerative Medicine
- Food Testing
- Research
- Others
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- South Africa
- Israel
- Rest of Middle East & Africa
- North America
- Frequently Asked Questions -
What will be the CAGR of the 3D bioprinting market over the forecast period (2024-2031)?
The CAGR of the 3D bioprinting market is projected to be 16.2% from 2024 to 2031.
What are the major factors driving the 3D bioprinting market growth?
Advances in regenerative medicine and tissue engineering and increased adoption in pharmaceutical and cosmetic industries are the major factor driving the growth of the 3D bioprinting market.
What are the key factors hampering the growth of the 3D bioprinting market?
Ensuring cell viability and regulatory hurdles for clinical applications are the major factors hampering the growth of the 3D bioprinting market.
Which will be the leading technology in the 3D bioprinting market in 2024?
In terms of technology, inkjet bioprinting is estimated to dominate the market revenue share in 2024.
Which are the major players operating in the 3D bioprinting market?
3D Bioprinting Solutions, Advanced Solutions Life Sciences, LLC, Allevi Inc., Aspect Biosystems Ltd., Bico group ab, Bio3D Technologies Pte. Ltd., Cellink Global, Collplant Biotechnologies Ltd., Cyfuse Biomedical K.K., Electro Optical Systems, Envisiontec GmbH, Foldink Life Science Technologies, Formlabs, Inc., GE Healthcare, Inventia Life Science PTY LTD, Nano 3D Biosciences, Inc., Optomec Inc., Organovo Holdings, Inc., Pandorum Technologies pvt. ltd., Precise Bio, Regemat 3D S.L., Regenovo Biotechnology Co. Ltd., Renishaw plc., Revotek co., ltd., Rokit Healthcare, inc., Stratasys Ltd.Vivax Bio, LLC, and Vivax Bio, LLC are the major players.
Which region will lead the 3D bioprinting market in 2024?
North America is expected to lead the 3D bioprinting market in 2024.